Recall: Teva- Bupropion 300mg - lower strength tabletHealth ProductsAug 9th, 2024 @ 12:00 PM
Basic Details
Category: Health products - Drugs
Issue: Health products - Product quality
Distribution: National
National
Product: TEVA-BUPROPION XL 300MG TABLETS
What to do: Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Products
| Brand | Product Name | Market Authorization | Dosage Form | Lot numbers | Strength |
|---|---|---|---|---|---|
| Teva | TEVA-BUPROPION XL | DIN 02439662 | Tablet (Extended-Release) | 100055815 & 100061092 | BUPROPION HYDROCHLORIDE 300mg |
Recall Monitor
Information presented from Recalls and Safety Alerts dataset, provided by the Government of Canada through the Open Government initiative and is subject to the Open Government License.
You can access this data free of charge via Recall Monitor, or through the Healthy Canadians website.
Get personalized SMS or Email notifications about recall alerts that matter by subscribing to Recall Monitor.
Recall Monitor is not endorsed by, or is an official product of the Government of Canada.
Made with in Vancouver, BC
© Mad Filaments Software Inc.